Assessment of the Durability of Cardioneuroablation Using Physiological Indices of Heart Rate Reactivity
NCT ID: NCT06697145
Last Updated: 2025-03-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2021-11-23
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardioneuroablation for Reflex Syncope
NCT03903744
Cardioneuroablation and Ventricular Proarrhythmia
NCT06458140
Cardioneuroablation for Reflex Syncope and Exercise Capacity
NCT06440291
Cardiac Autonomic Denervation for Cardio-inhibitory Syncope
NCT05572034
POLish Registry of CArdioneuroablation and CArdioneuromodulation
NCT07196397
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cardioneuroablation
Cardioneuroablation
Ablation of parasympathetic ganglia of the heart
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardioneuroablation
Ablation of parasympathetic ganglia of the heart
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* sinus rhythm
* clinical indications for cardioneuroablation for the treatment of vagally-mediated syncope
Exclusion Criteria
* known atropine hypersensitivity
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wroclaw Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Piotr Niewinski, MD
MD, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wroclaw Medical University
Wroclaw, Lower Silesian Voivodeship, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KB-331/2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.